Today, Apraciti submitted comments to the Federal eRulemaking Portal (https://www.regulations.gov) on the US Food and Drug Administrations (FDA) draft guidance, Content of Premarket Submissions for Management of Cybersecurity in Medical Devices. We continue to be encouraged by